Hospital
VHS Sinai-Grace Hospital INC
VHS Sinai-Grace Hospital INC was paid $96.77M by Medicaid between Jan 2018 and Dec 2024, across 430 billing codes. Its largest line is 99285, emergency room visit (most serious) — 22% of everything it billed.
33Billing provider infoVHS SINAI-GRACE HOSPITAL INC
DETROIT, MI 48235
DETROIT, MI 48235
33aNPI1760794044assigned 07/02/2010
33bProvider typeGeneral Acute Care Hospital
28Total paid$96.77M
24GClaims2,240,741
24DCodes billed430
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Michigan
Rank by total paid#9 of 86
Median peer was paid$21.55M
This provider vs. median4.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 431,266 | $17.96M | |
| 2019 | 436,377 | $18.53M | |
| 2020 | 329,616 | $14.70M | |
| 2021 | 290,685 | $13.29M | |
| 2022 | 283,787 | $12.55M | |
| 2023 | 278,099 | $11.47M | |
| 2024incomplete | 190,911 | $8.29M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 22% | 48,708 | 45,470 | $21.41M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 80,309 | 76,306 | $16.24M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 112,413 | 105,340 | $13.82M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 7.5% | 123,629 | 102,652 | $7.30M |
| G0378 | Hospital observation service, per hour | 6.9% | 16,812 | 15,464 | $6.69M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.9% | 38,189 | 35,535 | $2.78M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.1% | 7,173 | 7,044 | $2.02M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.0% | 5,448 | 5,407 | $1.92M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.3% | 15,343 | 14,240 | $1.26M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.2% | 2,299 | 2,279 | $1.12M |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 1.1% | 2,853 | 2,834 | $1.10M |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 13,009 | 12,602 | $1.05M |
418 more codes
| 71045 | Radiologic examination, chest; single view | 1.0% | 34,998 | $994K |
| 58558 | <1% | 632 | $925K | |
| 20610 | <1% | 5,515 | $921K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 1,492 | $636K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 10,490 | $625K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 10,069 | $601K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 27,700 | $593K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 2,272 | $590K |
| 80061 | Lipid panel | <1% | 9,102 | $553K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 18,629 | $541K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 1,525 | $488K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 7,200 | $471K |
| 76830 | Ultrasound, transvaginal | <1% | 7,693 | $431K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 9,115 | $430K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 7,891 | $407K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 3,485 | $365K |
| 76801 | <1% | 7,337 | $363K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 8,489 | $310K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 29,025 | $307K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 29,026 | $295K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,951 | $293K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 47,142 | $272K |
| 93975 | <1% | 2,856 | $267K | |
| H0032 | Mental health service plan development by non-physician | <1% | 1,979 | $232K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 2,229 | $229K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 2,197 | $219K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 3,985 | $211K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 1,541 | $205K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 6,868 | $199K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 62,953 | $191K |
| T1017 | Case management, billed per 15 minutes | <1% | 1,147 | $184K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 2,707 | $182K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 3,047 | $182K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,599 | $181K |
| 99218 | <1% | 744 | $174K | |
| 10060 | <1% | 1,807 | $158K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 3,170 | $150K |
| 72141 | <1% | 760 | $140K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,656 | $132K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 992 | $130K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 694 | $128K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 2,126 | $125K |
| 90837 | Psychotherapy session, about an hour | <1% | 983 | $120K |
| 86780 | <1% | 13,482 | $120K | |
| 76770 | <1% | 2,030 | $115K | |
| 81025 | <1% | 55,039 | $101K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 4,205 | $99K |
| 70486 | <1% | 3,420 | $99K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 908 | $97K |
| 93970 | <1% | 1,131 | $87K | |
| 76536 | <1% | 1,637 | $87K | |
| 80053 | Comprehensive metabolic panel | <1% | 29,134 | $87K |
| 72131 | <1% | 2,659 | $85K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 9,813 | $79K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,310 | $77K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,006 | $69K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 589 | $68K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 10,851 | $68K |
| 59025 | Fetal non-stress test | <1% | 838 | $68K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 8,902 | $66K |
| 84484 | <1% | 26,832 | $66K | |
| 76642 | <1% | 2,155 | $62K | |
| 72128 | <1% | 2,112 | $61K | |
| H0031 | Mental health assessment, by non-physician | <1% | 444 | $61K |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 5,367 | $61K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 930 | $58K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 2,917 | $58K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 125 | $54K |
| 97162 | <1% | 1,065 | $52K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 763 | $49K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 25,503 | $49K |
| 77066 | Tomosynthesis, mammo | <1% | 868 | $49K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 19,113 | $48K |
| 72100 | <1% | 3,090 | $47K | |
| 73564 | <1% | 7,861 | $47K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 11,008 | $47K |
| C8928 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report | <1% | 273 | $47K |
| 93971 | <1% | 930 | $43K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 10,610 | $43K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 62,899 | $42K |
| 82962 | <1% | 29,021 | $42K | |
| 86900 | <1% | 18,909 | $40K | |
| 12001 | <1% | 2,114 | $39K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 620 | $39K |
| 36430 | <1% | 296 | $38K | |
| 87625 | <1% | 2,136 | $37K | |
| 29515 | <1% | 376 | $37K | |
| 70496 | <1% | 470 | $37K | |
| 31575 | <1% | 219 | $37K | |
| 73030 | <1% | 6,737 | $36K | |
| 71271 | <1% | 643 | $35K | |
| 87480 | <1% | 5,315 | $35K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,411 | $35K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 1,057 | $35K |
| 74178 | <1% | 225 | $35K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 462 | $35K |
| 87660 | <1% | 5,200 | $35K | |
| 70491 | <1% | 337 | $35K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 133 | $34K |
| 58661 | <1% | 12 | $34K | |
| 93458 | <1% | 25 | $34K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 9,268 | $33K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 12,514 | $33K |
| 87510 | <1% | 5,113 | $32K | |
| J2704 | Injection, propofol, 10 mg | <1% | 19,457 | $32K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 674 | $30K |
| T1001 | Nursing assessment / evaluation | <1% | 309 | $29K |
| 92557 | <1% | 467 | $29K | |
| 73700 | <1% | 493 | $28K | |
| 81003 | <1% | 36,270 | $28K | |
| 97166 | <1% | 874 | $28K | |
| 73630 | <1% | 8,328 | $28K | |
| 77065 | Tomosynthesis, mammo | <1% | 617 | $27K |
| 73221 | <1% | 187 | $26K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 211 | $26K |
| 96367 | <1% | 972 | $25K | |
| 95811 | <1% | 53 | $25K | |
| 73610 | <1% | 7,662 | $25K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 262 | $25K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 28,708 | $25K |
| 73130 | <1% | 7,495 | $24K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 254 | $24K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 8,179 | $23K |
| 93797 | <1% | 392 | $21K | |
| 72170 | <1% | 5,632 | $21K | |
| 72110 | <1% | 533 | $21K | |
| 94726 | <1% | 387 | $21K | |
| 12002 | <1% | 1,480 | $21K | |
| 85027 | <1% | 34,811 | $20K | |
| 12011 | <1% | 1,411 | $20K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 213 | $20K |
| 93017 | <1% | 994 | $19K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,163 | $19K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,462 | $19K |
| 73562 | <1% | 3,101 | $19K | |
| 73590 | <1% | 4,085 | $17K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,114 | $17K |
| 70498 | <1% | 462 | $17K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 11,318 | $14K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 3,438 | $14K |
| 73110 | <1% | 4,136 | $14K | |
| 73560 | <1% | 1,204 | $14K | |
| 73502 | <1% | 2,876 | $14K | |
| A9270 | Non-covered item or service | <1% | 140,383 | $13K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 5,971 | $13K |
| 31500 | <1% | 38 | $13K | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 1,822 | $13K |
| 84702 | <1% | 13,012 | $13K | |
| 85610 | <1% | 22,160 | $12K | |
| 76870 | <1% | 730 | $12K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 73 | $12K |
| 83880 | <1% | 5,149 | $12K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,542 | $12K |
| 72070 | <1% | 980 | $12K | |
| 87340 | <1% | 7,602 | $11K | |
| 87467 | <1% | 2,130 | $11K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 25,931 | $11K |
| 94060 | <1% | 94 | $11K | |
| 82951 | <1% | 1,429 | $10K | |
| 83735 | <1% | 45,982 | $10K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 13 | $10K |
| 81001 | <1% | 20,185 | $10K | |
| 72156 | <1% | 27 | $10K | |
| 86850 | <1% | 18,859 | $10K | |
| 29125 | <1% | 1,165 | $10K | |
| 86870 | <1% | 125 | $10K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 7,255 | $10K |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 1,271 | $9K |
| 73080 | <1% | 2,503 | $9K | |
| 82550 | <1% | 3,565 | $9K | |
| 71250 | <1% | 169 | $9K | |
| 86901 | <1% | 18,861 | $9K | |
| 77336 | <1% | 149 | $9K | |
| 74174 | <1% | 75 | $9K | |
| 84100 | <1% | 7,184 | $8K | |
| 86803 | <1% | 1,489 | $7K | |
| 77080 | <1% | 122 | $7K | |
| 73090 | <1% | 2,718 | $7K | |
| 87631 | <1% | 7,026 | $7K | |
| 82607 | <1% | 2,152 | $7K | |
| 97161 | <1% | 85 | $7K | |
| 90686 | <1% | 439 | $7K | |
| 83690 | <1% | 18,414 | $7K | |
| 80074 | <1% | 1,026 | $6K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 24,831 | $6K |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 5,221 | $6K |
| 97116 | <1% | 1,426 | $6K | |
| 85730 | <1% | 18,235 | $6K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 14,207 | $5K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 16,283 | $5K |
| 92588 | <1% | 45 | $5K | |
| 73060 | <1% | 1,532 | $5K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 514 | $5K |
| 84439 | <1% | 2,834 | $5K | |
| 0011A | <1% | 221 | $5K | |
| C1729 | Catheter, drainage | <1% | 1,492 | $5K |
| 87077 | <1% | 3,833 | $5K | |
| 90732 | <1% | 60 | $5K | |
| 0012A | <1% | 156 | $5K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 14,617 | $5K |
| 73552 | <1% | 2,256 | $4K | |
| 74018 | <1% | 732 | $4K | |
| 93880 | <1% | 84 | $4K | |
| 83605 | <1% | 5,142 | $4K | |
| 20600 | <1% | 30 | $4K | |
| 82652 | <1% | 1,015 | $4K | |
| G0008 | Administration of influenza virus vaccine | <1% | 596 | $4K |
| 20605 | <1% | 36 | $4K | |
| 97597 | <1% | 48 | $4K | |
| 72040 | <1% | 265 | $4K | |
| 93925 | <1% | 39 | $4K | |
| Q3014 | Telehealth originating site facility fee | <1% | 234 | $3K |
| 86762 | <1% | 1,565 | $3K | |
| 80051 | <1% | 1,040 | $3K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 54 | $3K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 692 | $3K |
| 86787 | <1% | 1,070 | $3K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 94 | $3K |
| 71101 | <1% | 799 | $3K | |
| 82728 | <1% | 1,158 | $3K | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 1,330 | $3K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 16,655 | $3K |
| 82746 | <1% | 751 | $3K | |
| 72050 | <1% | 65 | $2K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 5,656 | $2K |
| Q2037 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | <1% | 145 | $2K |
| 90715 | <1% | 7,467 | $2K | |
| 90674 | <1% | 217 | $2K | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 3,729 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,506 | $2K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 3,733 | $2K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 25 | $2K |
| 87081 | <1% | 2,076 | $2K | |
| 86923 | <1% | 307 | $2K | |
| 76813 | <1% | 40 | $2K | |
| 87040 | <1% | 1,671 | $2K | |
| 74019 | <1% | 335 | $2K | |
| 88307 | <1% | 187 | $2K | |
| 10061 | <1% | 13 | $2K | |
| 87529 | <1% | 801 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,447 | $2K |
| 94660 | <1% | 263 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 7,551 | $2K |
| 84153 | <1% | 389 | $2K | |
| 83037 | <1% | 513 | $2K | |
| 84460 | <1% | 7,228 | $2K | |
| 84703 | <1% | 3,880 | $2K | |
| 84450 | <1% | 7,420 | $2K | |
| 73140 | <1% | 748 | $2K | |
| S0077 | Injection, clindamycin phosphate, 300 mg | <1% | 367 | $2K |
| 96376 | <1% | 8,213 | $2K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 3,058 | $1K |
| 83001 | <1% | 240 | $1K | |
| 29750 | <1% | 15 | $1K | |
| 92950 | <1% | 14 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 27,396 | $1K |
| 83002 | <1% | 209 | $1K | |
| 82248 | <1% | 4,086 | $1K | |
| 84132 | <1% | 3,145 | $1K | |
| 96415 | <1% | 30 | $1K | |
| 82570 | <1% | 1,262 | $1K | |
| 82670 | <1% | 136 | $1K | |
| 12013 | <1% | 108 | $1K | |
| 96523 | <1% | 51 | $1K | |
| 83540 | <1% | 996 | $1K | |
| 82043 | <1% | 668 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,325 | $1K |
| 85379 | <1% | 3,651 | $995.60 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 5,657 | $987.48 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 5,610 | $969.67 |
| 82803 | <1% | 437 | $883.42 | |
| 88304 | <1% | 833 | $878.97 | |
| 11721 | <1% | 939 | $866.63 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,935 | $802.56 |
| 97165 | <1% | 52 | $802.09 | |
| 96417 | <1% | 25 | $799.97 | |
| 74022 | <1% | 438 | $788.63 | |
| 29580 | <1% | 15 | $764.77 | |
| 88342 | <1% | 182 | $764.06 | |
| 84075 | <1% | 4,353 | $758.68 | |
| 82565 | <1% | 1,364 | $750.74 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 1,137 | $728.13 |
| 84481 | <1% | 143 | $726.10 | |
| 87070 | <1% | 999 | $719.01 | |
| 90656 | <1% | 30 | $650.48 | |
| 86140 | <1% | 577 | $641.47 | |
| 94010 | <1% | 41 | $632.81 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,022 | $631.40 |
| 88312 | <1% | 2,652 | $617.88 | |
| 85651 | <1% | 386 | $599.79 | |
| 82150 | <1% | 1,092 | $595.13 | |
| 83550 | <1% | 418 | $563.18 | |
| 84156 | <1% | 826 | $511.39 | |
| 82247 | <1% | 3,705 | $504.78 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 37 | $499.61 |
| 93922 | <1% | 129 | $486.20 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 152 | $476.28 |
| 82810 | <1% | 330 | $455.66 | |
| 11056 | <1% | 43 | $447.50 | |
| 84520 | <1% | 587 | $416.92 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 1,212 | $412.86 |
| 87807 | <1% | 924 | $399.89 | |
| 76820 | <1% | 59 | $373.27 | |
| 87205 | <1% | 1,045 | $369.19 | |
| 84403 | <1% | 60 | $362.48 | |
| 82010 | <1% | 1,750 | $355.43 | |
| 70360 | <1% | 71 | $318.40 | |
| 74420 | <1% | 13 | $317.97 | |
| 99152 | <1% | 29 | $308.90 | |
| 88341 | <1% | 13 | $302.94 | |
| C1760 | Closure device, vascular (implantable/insertable) | <1% | 30 | $289.05 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 688 | $287.65 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | <1% | 102 | $280.38 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 5,031 | $277.12 |
| 83615 | <1% | 517 | $261.64 | |
| 83050 | <1% | 426 | $254.53 | |
| 84154 | <1% | 68 | $243.14 | |
| J3415 | Injection, pyridoxine hcl, 100 mg | <1% | 561 | $226.68 |
| 84146 | <1% | 43 | $225.13 | |
| 82105 | <1% | 37 | $221.63 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 945 | $213.29 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 681 | $206.02 |
| 85014 | <1% | 1,125 | $205.71 | |
| S0028 | Injection, famotidine, 20 mg | <1% | 909 | $200.00 |
| 86592 | <1% | 94 | $187.10 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 194 | $186.41 |
| 80185 | <1% | 287 | $184.77 | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | <1% | 898 | $164.11 |
| 73600 | <1% | 29 | $151.44 | |
| 82540 | <1% | 136 | $149.11 | |
| 80143 | <1% | 125 | $144.73 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 457 | $142.58 |
| J2560 | Injection, phenobarbital sodium, up to 120 mg | <1% | 74 | $141.80 |
| 86696 | <1% | 61 | $139.40 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | <1% | 127 | $135.52 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 848 | $135.10 |
| 99153 | Mod sedat endo service >5yrs | <1% | 14 | $134.40 |
| 84295 | <1% | 533 | $131.23 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 1,475 | $129.86 |
| 85046 | <1% | 141 | $110.10 | |
| 85018 | <1% | 654 | $108.59 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 16 | $103.41 |
| 82140 | <1% | 214 | $101.17 | |
| 80076 | <1% | 86 | $95.15 | |
| 87075 | <1% | 96 | $93.67 | |
| 86038 | <1% | 25 | $78.58 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 324 | $78.20 |
| 81002 | <1% | 217 | $68.77 | |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | <1% | 191 | $59.36 |
| 84550 | <1% | 83 | $58.03 | |
| 85384 | <1% | 108 | $57.73 | |
| 86695 | <1% | 37 | $56.23 | |
| 82947 | <1% | 25 | $56.20 | |
| 82330 | <1% | 80 | $55.50 | |
| J0461 | Injection, atropine sulfate, 0.01 mg | <1% | 42 | $52.37 |
| 86703 | <1% | 58 | $51.68 | |
| 73620 | <1% | 12 | $48.48 | |
| 82040 | <1% | 275 | $48.30 | |
| 94729 | <1% | 391 | $42.32 | |
| 80164 | <1% | 94 | $41.27 | |
| 76821 | <1% | 46 | $35.58 | |
| J3411 | Injection, thiamine hcl, 100 mg | <1% | 280 | $31.38 |
| 88302 | <1% | 13 | $30.24 | |
| 82747 | <1% | 13 | $29.46 | |
| 72190 | <1% | 14 | $29.40 | |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | <1% | 40 | $28.13 |
| J1245 | Injection, dipyridamole, per 10 mg | <1% | 27 | $27.92 |
| 83021 | <1% | 13 | $27.48 | |
| 86701 | <1% | 38 | $27.36 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 381 | $23.24 |
| J0592 | Injection, buprenorphine hydrochloride, 0.1 mg | <1% | 19 | $21.43 |
| 73070 | <1% | 13 | $17.88 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 7,735 | $15.39 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 8,798 | $13.36 |
| 82948 | <1% | 303 | $13.09 | |
| 82272 | <1% | 106 | $9.46 | |
| 86359 | <1% | 14 | $8.89 | |
| 86360 | <1% | 14 | $8.89 | |
| 94727 | <1% | 16 | $8.82 | |
| 80177 | <1% | 12 | $8.33 | |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | <1% | 27 | $7.83 |
| 92567 | <1% | 13 | $7.00 | |
| 90632 | <1% | 61 | $4.97 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 233 | $4.20 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 506 | $3.52 |
| 85660 | <1% | 35 | $3.46 | |
| 90714 | <1% | 100 | $2.26 | |
| S0030 | Injection, metronidazole, 500 mg | <1% | 24 | $1.07 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 213 | $0.06 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 420 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 613 | $0.00 |
| A4648 | Tissue marker, implantable, any type, each | 0% | 29 | $0.00 |
| C1781 | Mesh (implantable) | 0% | 13 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 101 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 152 | $0.00 |
| C1769 | Guide wire | 0% | 962 | $0.00 |
| 96368 | 0% | 38 | $0.00 | |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 0% | 12 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 379 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 79 | $0.00 |
| 11045 | 0% | 78 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 155 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 0% | 12 | $0.00 |
| 11730 | 0% | 34 | $0.00 | |
| 76604 | 0% | 13 | $0.00 | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 0% | 977 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 331 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 1,781 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 1,223 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 459 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 262 | $0.00 |
| 92592 | 0% | 319 | $0.00 | |
| C1782 | Morcellator | 0% | 348 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 127 | $0.00 |
| 82542 | 0% | 63 | $0.00 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 0% | 16 | $0.00 |
| 73000 | 0% | 13 | $0.00 | |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBUTCHER, GINA (CFO)
| Provider | Location | Paid |
|---|---|---|
| Prime Healthcare Services - Garden City LLC | Garden City, MI | $31.29M |
| VHS Sinai-Grace Hospital INC | Detroit, MI | $1.47M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.